当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 现金流量表

亿帆医药

(002019)

  

流通市值:75.15亿  总市值:108.50亿
流通股本:8.43亿   总股本:12.16亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,010,617,822.022,610,574,244.991,293,722,368.934,972,807,608.06
  收到的税费返还57,743,351.4229,898,863.5913,997,112.5957,439,778.07
  收到其他与经营活动有关的现金99,646,943.8225,487,356.6760,156,223.22325,867,877.45
  经营活动现金流入小计4,168,008,117.262,665,960,465.251,367,875,704.745,356,115,263.58
  购买商品、接受劳务支付的现金2,033,633,003.531,085,764,244.38513,219,894.622,351,960,565.99
  支付给职工以及为职工支付的现金681,925,708.8456,407,888.41245,094,744.34817,038,414.03
  支付的各项税费242,308,454.75171,061,648.8673,383,525.2425,833,123.31
  支付其他与经营活动有关的现金776,425,775.9359,216,619.46251,339,322.841,302,916,875.42
  经营活动现金流出小计3,734,292,942.982,072,450,401.111,083,037,4874,897,748,978.75
  经营活动产生的现金流量净额433,715,174.28593,510,064.14284,838,217.74458,366,284.83
二、投资活动产生的现金流量:
  收回投资收到的现金50,000,00050,000,000-80,590,053.77
  取得投资收益收到的现金1,216,468.4845,468.44,000133,900
  处置固定资产、无形资产和其他长期资产收回的现金净额13,120,175.6311,218,959.598,995,530.4124,413,236.4
  投资活动现金流入小计64,336,644.0362,064,427.998,999,530.41105,137,190.17
  购建固定资产、无形资产和其他长期资产支付的现金467,049,489.96377,167,958.5215,715,287.35559,232,140.2
  投资支付的现金167,000,00050,000,000--
  支付其他与投资活动有关的现金26,993,250---
  投资活动现金流出小计661,042,739.96427,167,958.5215,715,287.35559,232,140.2
  投资活动产生的现金流量净额-596,706,095.93-365,103,530.51-206,715,756.94-454,094,950.03
三、筹资活动产生的现金流量:
  取得借款收到的现金2,037,180,314.9716,542,199.26361,846,346.491,856,928,064.2
  收到其他与筹资活动有关的现金---1,028,773.39
  筹资活动现金流入小计2,037,180,314.9716,542,199.26361,846,346.491,857,956,837.59
  偿还债务支付的现金1,423,712,474.91601,358,224342,560,478.621,776,066,217.05
  分配股利、利润或偿付利息支付的现金182,626,592.65167,235,960.7513,170,207.38171,577,683.56
  其中:子公司支付给少数股东的股利、利润19,600,00019,600,000--
  支付其他与筹资活动有关的现金66,092,314.446,179,406.083,299,162.9824,484,414.79
  筹资活动现金流出小计1,672,431,382774,773,590.83359,029,848.981,972,128,315.4
  筹资活动产生的现金流量净额364,748,932.9-58,231,391.572,816,497.51-114,171,477.81
四、汇率变动对现金及现金等价物的影响-14,049,796.84-24,481,532.3-14,429,757.72-3,969,598.42
五、现金及现金等价物净增加额187,708,214.41145,693,609.7666,509,200.59-113,869,741.43
  加:期初现金及现金等价物余额663,768,116.47663,768,116.47663,768,116.47777,637,857.9
  期末现金及现金等价物余额851,476,330.88809,461,726.23730,277,317.06663,768,116.47
补充资料:
  净利润-187,392,598.33-373,451,729.24
  资产减值准备-39,897,032.37-81,644,901.72
  固定资产和投资性房地产折旧-68,363,957.9-118,295,699.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-68,363,957.9-118,295,699.88
  无形资产摊销-108,723,267.06-216,741,066.93
  长期待摊费用摊销-3,127,658.58-13,513,076.77
  处置固定资产、无形资产和其他长期资产的损失-1,528,142.97--12,695,234.82
  固定资产报废损失-518,598.2-1,372,279.15
  公允价值变动损失-314,610.6-143,103.71
  财务费用-23,036,056.47-53,039,094.91
  投资损失-12,225,169.97-27,309,932.03
  递延所得税--11,835,781.77--19,849,706.76
  其中:递延所得税资产减少--9,751,806.37--13,013,324.67
    递延所得税负债增加--2,083,975.4--6,836,382.09
  存货的减少-106,319,695.22--202,111,610.4
  经营性应收项目的减少-64,431,021.19--109,042,870.66
  经营性应付项目的增加--10,471,471.04--115,234,067.3
  其他--5,038,568.38-18,054,927.05
  现金的期末余额-809,461,726.23-663,768,116.47
  减:现金的期初余额-663,768,116.47-777,637,857.9
  现金及现金等价物的净增加额-145,693,609.76--113,869,741.43
公告日期2026-10-242026-08-292026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑